USANA Cuts 2021 Outlook as Lockdowns Soften Third Quarter Sales
USANA gave preliminary third-quarter results and cut its fiscal 2021 outlook. Net sales for the quarter ending October 2 were expected at 265 million to 270 million dollars, compared with 299 million dollars a year earlier. Diluted earnings were expected at 1.28 to 1.33 dollars a share, compared with 1.44 dollars. Final results were planned for October 26, 2021.
Chief executive Kevin Guest said COVID-19 lockdowns disrupted customers, the sales force, shipping, and events, and that some product launches were delayed into 2022. Less favorable currency also hurt the quarter. Full-year net sales guidance was reduced to 1.18 billion to 1.20 billion dollars from 1.24 billion to 1.28 billion dollars. Diluted earnings guidance was reduced to 5.80 to 6.00 dollars from 6.15 to 6.50 dollars. Guest still expected sales growth of 4 percent to 6 percent and another record sales year.
The board increased the share repurchase authorization to 150 million dollars, including 14 million dollars that remained as of September 16, 2021. Purchases can be made in the open market or through block trades depending on market conditions and cash.
More USANA news
USANA Q3 Net Sales Fall 4% to $206 Million as Core Customers Slide; Company Trims 2026 Outlook
SALT LAKE CITY, Utah - November 3, 2026 USANA Health Sciences reported third-quarter 2026 net sales of $206 million on November 3, down 4 percent from $214 million a year earlier...
USANA Reports Second Quarter Sales of 223 Million Dollars and Net Loss on Impairment
SALT LAKE CITY, Utah -- August 4, 2026 USANA Health Sciences reported second-quarter 2026 net sales of 223 million dollars, down 5% from 236 million dollars a year earlier. The...
USANA Reports Flat First Quarter Net Sales of 250 Million Dollars
SALT LAKE CITY, Utah -- May 5, 2026 USANA Health Sciences reported fiscal first-quarter 2026 net sales of 250 million dollars, unchanged from the year-earlier quarter, as growth...
USANA Swings to Fourth-Quarter Loss as Active Customers Fall to 387,000
SALT LAKE CITY, Utah -- February 17, 2026 USANA Health Sciences reported fourth-quarter 2025 net sales of 226.2 million dollars, up 6 percent from 213.6 million dollars a year...
USANA Chief Executive Jim Brown Steps Down; Kevin Guest Returns as CEO
SALT LAKE CITY, Utah -- January 8, 2026 USANA Health Sciences said Jim Brown has stepped down as chief executive officer and president and that Kevin Guest, the company's...